Dalteparin vs placebo
Adverse events associated with the use of anticoagulants (e.g. bleeding) ‐ not measured · sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
- Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found